World Journal of Cardiovascular Diseases

Volume 4, Issue 9 (August 2014)

ISSN Print: 2164-5329   ISSN Online: 2164-5337

Google-based Impact Factor: 0.38  Citations  

Myocardial Protection during Cardiac Surgery: Warm Blood versus Crystalloid Cardioplegia

HTML  Download Download as PDF (Size: 2541KB)  PP. 422-431  
DOI: 10.4236/wjcd.2014.49053    3,555 Downloads   5,664 Views  Citations

ABSTRACT

Purpose: Prevention of myocardial injury is essential during cardiac surgery. Both crystalloid and blood cardioplegia are popular methods for myocardial protection. Most experimental studies have been in favor of blood cardioplegia. The objective of this study is to determine whether the use of warm blood cardioplegia (BCP) is superior to crystalloid cardioplegia (CCP) by means of myocardial injury markers and clinical outcome parameters. Materials and Methods: In a consecutive series of 293 patients, the first 150 received crystalloid cardioplegia, whereas the next 143 patients received blood cardioplegia. Postoperative myocardial injury was assessed by CTnI and CK-MB. Perioperative morbidity and mortality and clinical outcome parameters (need for inotropic support, ICU and hospital stay) were recorded. An unpaired student t-test was performed to analyse continuous postoperative variables relating to myocardial damage. The presence of possible confounders influencing the CTnI or CK-MB concentrations was tested using a student t-test for continuous variables, for categorical variables ANOVA was used. A final longitudinal model was created for CTnI and CK-MB. CTnI was analyzed by a mixed model with random intercept and slope. For all tests performed, statistical significance was 5%. Results: Both groups were well matched with respect to preoperative variables. No significant difference could be found in maximum postoperative levels of CTnI (8.8 ± 18.4 μg/l in BCP vs 9.6 ± 16.5 μg/l in CCP, p = 0.6455) or CK-MB (19.2 ± 31.0 μg/l in BCP vs 26.4 ± 41.5 μg/l in CCP, p = 0.1209). Nor was there any significant difference in other postoperative variables. Testing treatment effect over time proved only significant influence of the surgical intervention type on CTnI levels in time (p < 0.001). Conclusion: This study could not show significantly higher myocardial injury in the group of patients receiving crystalloid cardioplegia versus warm blood cardioplegia. This suggests that warm blood cardioplegia does not confer superior myocardial protection. Surgical intervention type has an important effect on CTnI concentration in time, while the type of cardioplegia does not.

Share and Cite:

Bruyn, H. , Gelders, F. , Gregoir, T. , Waelbers, V. , Starinieri, P. , Pauwels, J. , Lehaen, J. , Robic, B. , Yilmaz, A. , Mees, U. and Hendrikx, M. (2014) Myocardial Protection during Cardiac Surgery: Warm Blood versus Crystalloid Cardioplegia. World Journal of Cardiovascular Diseases, 4, 422-431. doi: 10.4236/wjcd.2014.49053.

Cited by

[1] Four decades of experience of prosthetic valve endocarditis reflect a high variety of diverse pathogens
Cardiovascular …, 2022
[2] СРАВНИТЕЛЬНЫЙ АНАЛИЗ ИСПОЛЬЗОВАНИЯ КРИСТАЛЛОИДНОЙ ФАРМАКОХОЛОДОВОЙ КАРДИОПЛЕГИИ И СОБСТВЕННОЙ МОДИФИКАЦИИ …
Клиническая и …, 2022
[3] Koroner bypass cerrahisinde kardiyoplejiye eklenen askorbik asit'in miyokard hasarı belirteçlerine etkisinin araştırılması
2021
[4] Вариант тепловой, кровяной, малообъемной кардиоплегии при реваскуляризации миокарда у взрослых пациентов
2021
[5] Warm blood cardioplegia versus cold crystalloid cardioplegia for coronary artery bypass grafting (CABG) in patients with low ejection fraction
2020
[6] Changes of biventricular function after CABG surgery: does cardioplegia type matter?
2020
[7] WARM VERSUS COLD INTERMITTENT BLOOD CARDIOPLEGIA FOR MYOCARDIAL PROTECTION DURING ON-PUMP CORONARY ARTERY BYPASS GRAFTING
2020
[8] Сравнение эффективности тепловой прерывистой кровяной кардиоплегии (KMgLid+ Кровь) и фармакохолодовой кристаллоидной (НТК-раствор) …
2018
[9] СРАВНЕНИЕ ЭФФЕКТИВНОСТИ ТЕПЛОВОЙ ПРЕРЫВИСТОЙ КРОВЯНОЙ КАРДИОПЛЕГИИ (KMGLID+ КРОВЬ) И ФАРМАКОХОЛОДОВОЙ КРИСТАЛЛОИДНОЙ (НТК-РАСТВОР) КАРДИОПЛЕГИИ ПРИ ОТКРЫТЫХ ОПЕРАЦИЯХ ПРЯМОЙ РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА
АНЕСТЕЗИОЛОГИЯ И РЕАНИМАТОЛОГИЯ, 2018
[10] Kardioplegijos metodikos įtaka širdies aritmijų pasireiškimui poišeminiu periodu ligoniams, kuriems atliekama aortovainikinių kraujagyslių jungčių suformavimo …
2018
[11] СРАВНЕНИЕ ЭФФЕКТИВНОСТИ ТЕПЛОВОЙ ПРЕРЫВИСТОЙ КРОВЯНОЙ КАРДИОПЛЕГИИ (KMGLID+ КРОВЬ) И ФАРМАКОХОЛОДОВОЙ …
2018
[12] Kardioplegijos metodikos įtaka širdies aritmijų pasireiškimui poišeminiu periodu ligoniams, kuriems atliekama aortovainikinių kraujagyslių jungčių …
2018
[13] To study the adequacy of myocardial protection with cardioplegia solution in patients undergoing cardiac surgery using CPK-MB as biomarker
The Pharma Innovation Journal, 2017
[14] Myocardial protection during CABG: Warm blood versus cold crystalloid cardioplegia, is there any difference?
Journal of the Egyptian Society of Cardio-Thoracic Surgery, 2016
[15] Повреждение миокарда в условиях кардиоплегии и искусственного кровообращения
Кардіохірургія та інтервенційна кардіологія, 2016

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.